Latest News

FDA OKs 1st Drug for Sinusitis With Nasal Polyps

illustration of sinusitis

Dupixent (dupilumab) is given by injection every two weeks. It was approved to treat patients with nasal polyps and chronic rhinosinusitis — defined as a prolonged inflammation of the sinuses and nasal cavity, the FDA said.

Source link




Related posts

Samenvatting: Takeda presenteert langetermijngegevens in ALK + NSCLC met ALUNBRIGĀ® (brigatinib) blijft superioriteit in de eerstelijn aantonen na twee jaar follow-up

Newsemia

Medical News Today: What to know about hair growth

Newsemia

Synthesis considers how being smart helps you at school and school helps you become smarter

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy